RENX ENTERPRISES CORP (RENX) Stock Fundamental Analysis

USA Nasdaq NASDAQ:RENX • US78637J2042

0.1426 USD
+0 (+1.06%)
At close: Feb 6, 2026
0.1403 USD
0 (-1.61%)
After Hours: 2/6/2026, 8:03:48 PM
Fundamental Rating

0

Taking everything into account, RENX scores 0 out of 10 in our fundamental rating. RENX was compared to 62 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of RENX have multiple concerns. RENX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year RENX has reported negative net income.
  • RENX had a negative operating cash flow in the past year.
RENX Yearly Net Income VS EBIT VS OCF VS FCFRENX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M -2M -4M -6M -8M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -30.14%, RENX is doing worse than 83.87% of the companies in the same industry.
  • RENX has a Return On Equity of -279.47%. This is amonst the worse of the industry: RENX underperforms 82.26% of its industry peers.
Industry RankSector Rank
ROA -30.14%
ROE -279.47%
ROIC N/A
ROA(3y)-46.7%
ROA(5y)N/A
ROE(3y)-589.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RENX Yearly ROA, ROE, ROICRENX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -500 -1K

1.3 Margins

  • The Gross Margin of RENX (1.62%) is worse than 77.42% of its industry peers.
  • The Profit Margin and Operating Margin are not available for RENX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RENX Yearly Profit, Operating, Gross MarginsRENX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -1K -2K -3K -4K

0

2. Health

2.1 Basic Checks

  • RENX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, RENX has more shares outstanding
  • RENX has a worse debt/assets ratio than last year.
RENX Yearly Shares OutstandingRENX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 500K 1M
RENX Yearly Total Debt VS Total AssetsRENX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • RENX has an Altman-Z score of -2.41. This is a bad value and indicates that RENX is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of RENX (-2.41) is worse than 83.87% of its industry peers.
  • RENX has a Debt/Equity ratio of 4.92. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 4.92, RENX is doing worse than 83.87% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.92
Debt/FCF N/A
Altman-Z -2.41
ROIC/WACCN/A
WACC5.49%
RENX Yearly LT Debt VS Equity VS FCFRENX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M -4M

2.3 Liquidity

  • A Current Ratio of 0.12 indicates that RENX may have some problems paying its short term obligations.
  • RENX has a worse Current ratio (0.12) than 91.94% of its industry peers.
  • A Quick Ratio of 0.09 indicates that RENX may have some problems paying its short term obligations.
  • The Quick ratio of RENX (0.09) is worse than 91.94% of its industry peers.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.09
RENX Yearly Current Assets VS Current LiabilitesRENX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 75.75% over the past year.
  • Looking at the last year, RENX shows a very strong growth in Revenue. The Revenue has grown by 1569.89%.
EPS 1Y (TTM)75.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.21%
Revenue 1Y (TTM)1569.89%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3223.46%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RENX Yearly Revenue VS EstimatesRENX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 50K 100K 150K 200K

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RENX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RENX Price Earnings VS Forward Price EarningsRENX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RENX Per share dataRENX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • RENX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

RENX ENTERPRISES CORP

NASDAQ:RENX (2/6/2026, 8:03:48 PM)

After market: 0.1403 0 (-1.61%)

0.1426

+0 (+1.06%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners4.35%
Inst Owner ChangeN/A
Ins Owners42.77%
Ins Owner ChangeN/A
Market Cap1.27M
Revenue(TTM)1.54M
Net Income(TTM)-11.78M
AnalystsN/A
Price TargetN/A
Short Float %10.55%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.82
P/FCF N/A
P/OCF N/A
P/B 0.3
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-6.89
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0.17
BVpS0.47
TBVpS-2.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -30.14%
ROE -279.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.62%
FCFM N/A
ROA(3y)-46.7%
ROA(5y)N/A
ROE(3y)-589.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 4.92
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 403.43%
Cap/Sales 55.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.09
Altman-Z -2.41
F-Score5
WACC5.49%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.21%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1569.89%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3223.46%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-79.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y71.36%
OCF growth 3YN/A
OCF growth 5YN/A

RENX ENTERPRISES CORP / RENX FAQ

What is the fundamental rating for RENX stock?

ChartMill assigns a fundamental rating of 0 / 10 to RENX.


What is the valuation status for RENX stock?

ChartMill assigns a valuation rating of 0 / 10 to RENX ENTERPRISES CORP (RENX). This can be considered as Overvalued.


What is the profitability of RENX stock?

RENX ENTERPRISES CORP (RENX) has a profitability rating of 0 / 10.